(Hyoscine Butylbromide) for Abdominal Pain Associated With Cramping on Demand Basis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of this pilot study is to assess effects of Hyoscine Butylbromide (HBB)
20 mg in comparison to placebo, when used as needed, as measured by the subject's assessment
of intensity of abdominal pain associated with cramping (APC) in the treatment of two
episodes.